542 related articles for article (PubMed ID: 17600130)
1. Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule.
Trzpis M; McLaughlin PM; de Leij LM; Harmsen MC
Am J Pathol; 2007 Aug; 171(2):386-95. PubMed ID: 17600130
[TBL] [Abstract][Full Text] [Related]
2. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.
Patriarca C; Macchi RM; Marschner AK; Mellstedt H
Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002
[TBL] [Abstract][Full Text] [Related]
3. Role of the EpCAM (CD326) in prostate cancer metastasis and progression.
Ni J; Cozzi PJ; Duan W; Shigdar S; Graham PH; John KH; Li Y
Cancer Metastasis Rev; 2012 Dec; 31(3-4):779-91. PubMed ID: 22718399
[TBL] [Abstract][Full Text] [Related]
4. Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer.
Benko G; Spajić B; Krušlin B; Tomas D
Urol Oncol; 2013 May; 31(4):468-74. PubMed ID: 21514185
[TBL] [Abstract][Full Text] [Related]
5. EpCAM in morphogenesis.
Trzpis M; Bremer E; McLaughlin PM; de Leij LF; Harmsen MC
Front Biosci; 2008 May; 13():5050-5. PubMed ID: 18508569
[TBL] [Abstract][Full Text] [Related]
6. Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.
Seligson DB; Pantuck AJ; Liu X; Huang Y; Horvath S; Bui MH; Han KR; Correa AJ; Eeva M; Tze S; Belldegrun AS; Figlin RA
Clin Cancer Res; 2004 Apr; 10(8):2659-69. PubMed ID: 15102668
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of EpCAM in cancer and stem cell signaling.
Munz M; Baeuerle PA; Gires O
Cancer Res; 2009 Jul; 69(14):5627-9. PubMed ID: 19584271
[TBL] [Abstract][Full Text] [Related]
8. EpCAM in carcinogenesis: the good, the bad or the ugly.
van der Gun BT; Melchers LJ; Ruiters MH; de Leij LF; McLaughlin PM; Rots MG
Carcinogenesis; 2010 Nov; 31(11):1913-21. PubMed ID: 20837599
[TBL] [Abstract][Full Text] [Related]
9. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
Yamashita T; Budhu A; Forgues M; Wang XW
Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
Yanamoto S; Kawasaki G; Yoshitomi I; Iwamoto T; Hirata K; Mizuno A
Oral Oncol; 2007 Oct; 43(9):869-77. PubMed ID: 17207659
[TBL] [Abstract][Full Text] [Related]
11. The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP.
Münz M; Zeidler R; Gires O
Cancer Lett; 2005 Jul; 225(1):151-7. PubMed ID: 15922867
[TBL] [Abstract][Full Text] [Related]
12. EpCAM (CD326) finding its role in cancer.
Baeuerle PA; Gires O
Br J Cancer; 2007 Feb; 96(3):417-23. PubMed ID: 17211480
[TBL] [Abstract][Full Text] [Related]
13. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation.
Münz M; Kieu C; Mack B; Schmitt B; Zeidler R; Gires O
Oncogene; 2004 Jul; 23(34):5748-58. PubMed ID: 15195135
[TBL] [Abstract][Full Text] [Related]
14. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.
Rao CG; Chianese D; Doyle GV; Miller MC; Russell T; Sanders RA; Terstappen LW
Int J Oncol; 2005 Jul; 27(1):49-57. PubMed ID: 15942643
[TBL] [Abstract][Full Text] [Related]
15. EpCAM as Modulator of Tissue Plasticity.
Fagotto F
Cells; 2020 Sep; 9(9):. PubMed ID: 32961790
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines.
Kimura O; Takahashi T; Ishii N; Inoue Y; Ueno Y; Kogure T; Fukushima K; Shiina M; Yamagiwa Y; Kondo Y; Inoue J; Kakazu E; Iwasaki T; Kawagishi N; Shimosegawa T; Sugamura K
Cancer Sci; 2010 Oct; 101(10):2145-55. PubMed ID: 20707805
[TBL] [Abstract][Full Text] [Related]
17. EpCAM duality becomes this molecule in a new Dr. Jekyll and Mr. Hyde tale.
Herreros-Pomares A; Aguilar-Gallardo C; Calabuig-Fariñas S; Sirera R; Jantus-Lewintre E; Camps C
Crit Rev Oncol Hematol; 2018 Jun; 126():52-63. PubMed ID: 29759567
[TBL] [Abstract][Full Text] [Related]
18. EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder.
Brunner A; Prelog M; Verdorfer I; Tzankov A; Mikuz G; Ensinger C
J Clin Pathol; 2008 Mar; 61(3):307-10. PubMed ID: 17586680
[TBL] [Abstract][Full Text] [Related]
19. Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases.
Cimino A; Halushka M; Illei P; Wu X; Sukumar S; Argani P
Breast Cancer Res Treat; 2010 Oct; 123(3):701-8. PubMed ID: 20012351
[TBL] [Abstract][Full Text] [Related]
20. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
